LIBERVANT Drug Patent Profile

✉ Email this page to a colleague

When do Libervant patents expire, and when can generic versions of Libervant launch?

Libervant is a drug marketed by Aquestive and is included in one NDA. There is one patent protecting this drug.

This drug has twenty patent family members in eight countries.

The generic ingredient in LIBERVANT is diazepam. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diazepam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Libervant

A generic version of LIBERVANT was approved as diazepam by MYLAN on September 4^th, 1985.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LIBERVANT?
What are the global sales for LIBERVANT?
What is Average Wholesale Price for LIBERVANT?

Summary for LIBERVANT

International Patents:	20
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Patent Applications:	4,158
What excipients (inactive ingredients) are in LIBERVANT?	LIBERVANT excipients list
DailyMed Link:	LIBERVANT at DailyMed

Drug patent expirations by year for LIBERVANT

Pharmacology for LIBERVANT

Drug Class	Benzodiazepine

US Patents and Regulatory Information for LIBERVANT

LIBERVANT is protected by one US patents and one FDA Regulatory Exclusivity.

Patents protecting LIBERVANT

Pharmaceutical compositions with enhanced permeation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

FDA Regulatory Exclusivity protecting LIBERVANT

NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-001	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-004	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-002	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for LIBERVANT

See the table below for patents covering LIBERVANT around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Israel	273479	תכשירי רוקחות עם חדירות משופרת (Pharmaceutical compositions with enhanced permeation)	⤷ Sign Up
Israel	262751	תכשירי רוקחות עם חדירה מוגברת (Pharmaceutical compositions with enhanced permeation)	⤷ Sign Up
China	111132670	具有增强的渗透的药物组合物 (PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration